[Histamine H2-receptor blockade and thrombosis prophylaxis with heparin in tetanus. A case report (author's transl)].
The use of "low-dose" heparin for the purpose of the prophylaxis of thrombosis is not yet general in the treatment of tetanus because this therapy may increase the risk of bleeding gastrointestinal stress-ulcers. The combination of heparin with histamine H2-receptor blockers, however, may be of therapeutic benefit and may reduce this complication as well as thrombosis. A case of tetanus and its therapy is reported.
D000667:Ampicillin / Q000627:therapeutic use; D001418:Baclofen / Q000627:therapeutic use; D002927:Cimetidine / Q000627:therapeutic use; D003975:Diazepam / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use*; D006635:Histamine H2 Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010437:Peptic Ulcer / Q000517:prevention & control; D013742:Tetanus / Q000628:therapy*; D013743:Tetanus Antitoxin / Q000627:therapeutic use; D013745:Tetanus Toxoid / Q000627:therapeutic use; D013927:Thrombosis / Q000517:prevention & control*
D006635:Histamine H2 Antagonists; D013743:Tetanus Antitoxin; D013745:Tetanus Toxoid; D000667:Ampicillin; D002927:Cimetidine; D006493:Heparin; D001418:Baclofen; D003975:Diazepam
Histamin H2-Receptorenblockade und Thromboseprophylaxe mit Heparin beim Tetanus. Ein Fallbericht.